Single-center experience of extracorporeal membrane oxygenation mainly anticoagulated with nafamostat mesilate

Bleeding remains the chief concern during extracorporeal membrane oxygenation (ECMO). Recently, several studies proposed nafamostat mesilate (NM) as an alternative anticoagulant to heparin due to reduced bleeding complications and comparable thromboembolic episodes. The aim of this study was to eval...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thoracic disease 2019-07, Vol.11 (7), p.2861-2867
Hauptverfasser: Han, Woosik, San Bok, Jin, Cho, Hyun Jin, Yu, Jae Hyeon, Na, Myung Hoon, Kang, Shinkwang, Kang, Min-Woong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!